A naukri.com initiative
Bioengineer
1w
374
Image Credit: Bioengineer
Wilms Tumors: The Role of Genes and Imprinting in Driving Cancer Development
- Researchers at JMU and Wellcome Sanger Institute uncover genetic and epigenetic drivers of Wilms’ tumors, a form of malignant kidney cancer affecting children.
- The study, utilizing the JMU Wilms tumor biobank, reveals insights into hereditary predispositions leading to pediatric malignancies.
- Nearly 1,800 tumor samples collected over 28 years aid in understanding familial and bilateral cases, with a genetic predisposition identification rate exceeding 90%.
- The research confirms a genetic cascade involving the WT1 gene, IGF2 activation, and WNT pathway hyperactivation in Wilms’ tumor development.
- Epigenetic disturbances in IGF2 imprinting are identified, showcasing a new dimension of tumor predisposition through mosaicism.
- The study highlights a diverse genetic architecture and the role of epigenetic dysregulation in Wilms tumorigenesis.
- Recognition of hereditary components in childhood kidney tumors necessitates comprehensive molecular testing for early detection and personalized management.
- The research integrates genomic technologies to offer a holistic understanding of Wilms tumor heredity and epigenetics, paving the way for targeted therapies.
- Insights from this study redefine genetic counseling approaches by differentiating between genetic inheritance and epigenetic alterations.
- The collaboration between JMU and Wellcome Sanger Institute sets a new standard for unraveling hereditary cancer syndromes, promising improved clinical outcomes.
Read Full Article
22 Likes
For uninterrupted reading, download the app